Table 3. Factors associated with available PTH levels within 6 months of chronic hypercalcemia using a complete case analysis (n=4,544).
Covariate | Odds ratio (95% CI) | P value |
---|---|---|
Age | 0.003 | |
<30 years | Reference | |
30–39 years | 2.4 (1.2–4.6) | 0.01 |
40–49 years | 2.5 (1.4–4.7) | 0.003 |
50–59 years | 2.4 (1.3–4.2) | 0.003 |
60–69 years | 1.7 (0.94–2.9) | 0.08 |
70–79 years | 1.8 (1.003–3.1) | 0.049 |
≥80 years | 1.7 (0.96–3.1) | 0.07 |
Sex | <0.001 | |
Male | Reference | |
Female | 1.4 (1.2–1.6) | <0.001 |
Insurance status | 0.005 | |
Private | Reference | |
Medicare | 0.84 (0.70–1.02) | 0.07 |
Medicaid | 0.62 (0.5–0.8) | <0.001 |
Other/uninsured/unknown | 0.86 (0.7–1.1) | 0.22 |
Laboratory values | ||
Calcium | <0.001 | |
<11.0 mg/dL | Reference | |
11.1–11.5 mg/dL | 2.8 (2.4–3.3) | <0.001 |
11.6–12.0 mg/dL | 3.7 (3.0–4.6) | <0.001 |
>12.0 mg/dL | 1.4 (1.1–1.7) | 0.008 |
Creatinine | 0.84 (0.70–1.01) | 0.07 |
25-OH vitamin D | 0.995 (0.992–0.999) | 0.01 |
Indications for surgery | ||
Kidney stones | 1.6 (1.3–1.9) | <0.001 |
Osteoporosis | 2.2 (1.9–2.5) | <0.001 |
Bone fracture | 0.72 (0.55–0.94) | 0.02 |
PTH, parathyroid hormone; CI, confidence interval.